Andraos, E., Dignac, J., & Meggetto, F. (2021). NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target. Cancers (Basel).
Chicago Style CitationAndraos, Elissa, Joséphine Dignac, and Fabienne Meggetto. "NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target." Cancers (Basel) 2021.
MLA CitationAndraos, Elissa, Joséphine Dignac, and Fabienne Meggetto. "NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target." Cancers (Basel) 2021.
Warning: These citations may not always be 100% accurate.